At Moats and Monopolies, we focus on long only, high quality businesses but sometimes we like a little asymmetric risk/reward opportunity. The Beauty Health Company has been incredibly volatile over the past couple of years as investors have grown weary that the company may never be profitable. The company still isn't profitable, causing a sell off after earnings after a $17 million write off for replacing flagship models with technical issues combined with declining revenues.
The Beauty Health Company (NASDAQ:SKIN ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and CEO Michael Monahan - CFO Conference Call Participants Alec Legg - Canaccord Genuity Allen Gong - JPMorgan Macauley Kilbane - William Blair Joseph Federico - Stifel Neil Goh - TD Cowen Operator Good afternoon, and welcome to The Beauty Health Company Second Quarter 2024 Earnings Conference Call. [Operator Instructions].
While the top- and bottom-line numbers for Beauty Health (SKIN) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.